Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffold

被引:38
作者
Ohkanda, J
Lockman, JW
Kothare, MA
Qian, YM
Blaskovich, MA
Sebti, SM
Hamilton, AD
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Univ S Florida, Drug Discovery Program, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[3] Univ S Florida, Dept Oncol & Biochem, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Mol Biol, Tampa, FL 33612 USA
关键词
D O I
10.1021/jm0103099
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By modification of key carboxylate, hydrophobic, and zinc-binding groups projected from a sterically restricted terphenyl scaffold, a series of simple and nonpeptide mimetics of the Cys-Val-Ile-Met tetrapeptide substrate of protein farnesyltransferase (FTase) have been designed and synthesized. A crystal structure of 4-nitro-2-phenyl-3'-methoxycarbonylbiphenyl shows that the triphenyl fragment provides a large hydrophobic surface that potentially mimics the hydrophobic side chains of the three terminal residues in the tetrapeptide. 2-Phenyl-3-(N-(1-(4-eyanobenzyl)-1H-imidazol-5-yl)methyl)amino-3'carboxylbiphenyl, in which the free thiol group was replaced with a 1-(4-cyanobenzyl)imidazole group, shows submicromolar inhibition activity against FTase in vitro and inhibits H-Ras processing in whole cells.
引用
收藏
页码:177 / 188
页数:12
相关论文
共 30 条
  • [1] Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase
    Anthony, NJ
    Gomez, RP
    Schaber, MD
    Mosser, SD
    Hamilton, KA
    O'Neil, TJ
    Koblan, KS
    Graham, SL
    Hartman, GD
    Shah, D
    Rands, E
    Kohl, NE
    Gibbs, JB
    Oliff, AI
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3356 - 3368
  • [2] RAS GENES
    BARBACID, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 779 - 827
  • [3] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF A SERIES OF N-(BIPHENYLYLMETHYL)IMIDAZOLES AS POTENT, ORALLY ACTIVE ANTIHYPERTENSIVES
    CARINI, DJ
    DUNCIA, JV
    ALDRICH, PE
    CHIU, AT
    JOHNSON, AL
    PIERCE, ME
    PRICE, WA
    SANTELLA, JB
    WELLS, GJ
    WEXLER, RR
    WONG, PC
    YOO, SE
    TIMMERMANS, PBMWM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2525 - 2547
  • [4] CASEY PJ, 1992, J LIPID RES, V33, P1731
  • [5] CHEN WJ, 1993, J BIOL CHEM, V268, P9675
  • [6] DER CJ, 1991, CANCER CELL-MON REV, V3, P331
  • [7] FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC
    GIBBS, JB
    OLIFF, A
    KOHL, NE
    [J]. CELL, 1994, 77 (02) : 175 - 178
  • [8] THE BIOCHEMISTRY OF RAS P21
    GRAND, RJA
    OWEN, D
    [J]. BIOCHEMICAL JOURNAL, 1991, 279 : 609 - 631
  • [9] Synthesis and binding behavior of an artificial receptor based on "upper rim" functionalized calix[5]arene
    Haino, T
    Matsumura, K
    Harano, T
    Yamada, K
    Saijyo, Y
    Fukazawa, Y
    [J]. TETRAHEDRON, 1998, 54 (40) : 12185 - 12196
  • [10] Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase
    Hunt, JT
    Lee, VG
    Leftheris, K
    Seizinger, B
    Carboni, J
    Mabus, J
    Ricca, C
    Yan, N
    Manne, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) : 353 - 358